BRAF and malignant colon neoplasm: Genetic markers were selected to represent the pathways most frequently altered in colon cancer, such as the WNT-pathway (surrogate marker osteopontin), mutations in the oncogenes KRAS and BRAF, and the DNA microsatellite status.